The available data allows for the following conclusion: Carriers of BRCA1 mutations diagnosed with BC may experience several advantages from early oophorectomy, such as a lower incidence of second primary ovarian cancers and a reduction in BC-related mortality [45]. The gene discussed is BRCA1; the disease is ovarian carcinoma.